Woodline Partners »

Adicet Bio Ord shares owned by Woodline Partners

Quarter-by-quarter ownership of Adicet Bio Ord (ACET) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Adicet Bio Ord

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio Ord held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio Ord by Woodline Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.3M 625k 8.42

More positions owned by Woodline Partners

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Johnson & Johnson (JNJ)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Texas Instruments Incorporated (TXN)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Verizon Communications (VZ)
Revolution Medicines (RVMD)

View all positions for Woodline Partners

Top funds holding Adicet Bio Ord

Franklin Resources
Woodline Partners
Vanguard Group
Prosight Management
Renaissance Technologies
Goldman Sachs Group
Stonepine Capital Management
Alyeska Investment Group
Carlyle
Acadian Asset Management
ADAR1 Capital Management
DAFNA Capital Management
Geode Capital Management
Luminus Management
Squarepoint Ops

View all funds holding Adicet Bio Ord